Dr. William Holderman
Claim this profileDigestive Health Specialists
Studies Inflammatory Bowel Disease
Studies Ulcerative Colitis
8 reported clinical trials
7 drugs studied
Affiliated Hospitals
Clinical Trials William Holderman is currently running
Mirikizumab
for Crohn's Disease
This trial is testing mirikizumab to see if it can help people with Crohn's disease feel better over a long time and ensure it is safe. The drug works by reducing gut inflammation.
Recruiting2 awards Phase 3
Mirikizumab
for Ulcerative Colitis
This trial is testing mirikizumab, a medication for people with severe ulcerative colitis. It aims to see if the drug can reduce gut inflammation by blocking a protein that causes it. The study will last several years. Mirikizumab has shown positive results in early tests for ulcerative colitis.
Recruiting2 awards Phase 31 criteria
More about William Holderman
Clinical Trial Related5 years of experience running clinical trials · Led 8 trials as a Principal Investigator · 5 Active Clinical TrialsTreatments William Holderman has experience with
- Mirikizumab
- Vedolizumab
- IMU-838
- Tofacitinib
- Adalimumab
- Ustekinumab
Breakdown of trials William Holderman has run
Inflammatory Bowel Disease
Ulcerative Colitis
Ulcer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does William Holderman specialize in?
William Holderman focuses on Inflammatory Bowel Disease and Ulcerative Colitis. In particular, much of their work with Inflammatory Bowel Disease has involved treating patients, or patients who are undergoing treatment.
Is William Holderman currently recruiting for clinical trials?
Yes, William Holderman is currently recruiting for 5 clinical trials in Tacoma Washington. If you're interested in participating, you should apply.
Are there any treatments that William Holderman has studied deeply?
Yes, William Holderman has studied treatments such as Mirikizumab, Vedolizumab, IMU-838.
What is the best way to schedule an appointment with William Holderman?
Apply for one of the trials that William Holderman is conducting.
What is the office address of William Holderman?
The office of William Holderman is located at: Digestive Health Specialists, Tacoma, Washington 98405 United States. This is the address for their practice at the Digestive Health Specialists.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.